Patients'characteristic survey concomitantly to the Post Marketing Surveillance(PMS) of Spiriva Respimat

Trial Profile

Patients'characteristic survey concomitantly to the Post Marketing Surveillance(PMS) of Spiriva Respimat

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 22 Feb 2017

At a glance

  • Drugs Tiotropium bromide (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Sponsors Nippon Boehringer Ingelheim
  • Most Recent Events

    • 21 Feb 2017 Status changed from not yet recruiting to active, no longer recruiting.
    • 27 May 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top